Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China

AIDS

Volumn 24, Issue 7, 2010, Pages 983-990

  Cysique, Lucette A ^a,f   Letendre, Scott L ^b   Ake, Christopher ^a   Jin, Hua ^a,c   Franklin, Donald R ^a   Gupta, Saurabh ^a   Shi, Chuan ^d   Yu, Xin ^d   Wu, Zunyou ^e   Abramson, Ian S ^b   Grant, Igor ^a   Heaton, Robert K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Antiretroviral therapy; China; Highly active; HIV AIDS; Incidence studies; Longitudinal studies; Neurocognitive disorders; Neuropsychological tests

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD DONOR; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CHINA; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; MORBIDITY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RURAL AREA;

EID: 77950937261     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833336c8     Document Type: Article

References (37)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, et al. Updated research nosology for HIV-associated neuro-cognitive disorders. Neurology 2007; 69:1789-1799.
2. Robertson KR, Nakasujja N, Wong M, Musisi S, Katabira E, Parsons TD, et al. Pattern of neuropsychological performance among HIV positive patients in Uganda. BMC Neurol 2007; 7:8.
3. Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, et al. Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 2007; 68:350-355.
4. Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon S, Flanigan T. Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc 2006; 12:424-430.
5. Cysique LA, Jin H, Franklin DR, Morgan EE, Shi C, Yu X, et al. Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J Int Neuropsychol Soc 2007; 13:781-790.
6. Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, et al. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neuro-virol 2008; 7:1-14.
7. Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, et al. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 2008; 71:50-56.
8. Robertson K, Liner J, Heaton R. Neuropsychological assessment of HIV-infected populations in international settings. Neuro-psychol Rev 2009; 19:232-249.
9. Cole MA, Margolick JB, Cox C, Li X, Selnes OA, Martin EM, et al. Longitudinally preserved psychomotor performance in long-term asymptomatic HIV-infected individuals. Neurology 2007; 69:2213-2220.
10. Cysique LA, Maruff P, Brew BJ. Variable benefit in neuropsy-chological function in HIV-infected HAART-treated patients. Neurology 2006; 66:1447-1450.
11. Ferrando SJ, Rabkin JG, van Gorp WG, Lin S-H, McElhiney M. Longitudinal improvement in psychomotor processing is associated with potent antiretroviral therapy in HIV-1 infection. J Neuropsychiatry Clin Neurosci 2003; 15:208-214.
12. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007; 21:1915-1921.
13. Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 2007; 45:174-182. (Pubitemid 46869810)
14. Cysique LA, Brew BJ. Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review. Neuropsychol Rev 2009; 19:169-185.
15. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008; 65:65-70.
16. Dou H, Kingsley JD, Mosley RL, Gelbard HA, Gendelman HE. Neuroprotective strategies for HIV-1 associated dementia. Neurotox Res 2004; 6:503-521.
17. McSweeny AJ, Naugle RI, Chelune GJ, Luders H. 'T scores for change': an illustration of a regression approach to depicting change in clinical neuropsychology. Clin Neuropsychol 1993; 7:300-312.
18. Temkin N, Heaton R, Grant I, Dikmen S. Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc 1999; 5:357-369.
19. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK. Predictive validity of Global Deficit Scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 2004; 26:307-319.
20. Heaton R, Miller W, Taylor MJ, Grant I. Revised comprehensive norms for an expended Halstead Reitan battery: demographi-cally adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources; 2004.
21. Chelune G, Heaton R, Lehman R. Neuropsychological and personality correlates of patients' complaints of disability. In: Tarter R, Goldstein G, editors. Advances in clinical neuro-psychology. New York: New York Plenum Press; 1986. pp. 95-126.
22. Heaton R, Marcotte TD, Rivera Mindt M, Sadek J, Moore D, Bentley H, et al. The impact of HIV-associated neuropsycho-logical impairment on everyday functioning. J Int Neuropsy-chol Soc 2004; 10:317-331.
23. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess 1996; 67:588-597.
24. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio: TX: Psychological Corporation; 1996.
25. Grant I, Atkinson HJ, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, McCutchan AJ. Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychological testing and magnetic resonance imaging. Ann Intern Med 1987; 107:828-836.
26. Collie A, Maruff P, Darby D, McStephen M. The effects of practice on the cognitive test performance of neurologically normal individuals assessed at brief test-retest intervals. J Int Neuropsychol Soc 2003; 9:419-428.
27. Heaton R, TemkinN,DikmenS, AvitableN,TaylorM,Marcotte T, Grant I. Detecting change: a comparison of three neuro-psychological methods, using normal and clinical samples. Arch Clin Neuropsychol 2001; 16:75-91.
28. Levine A, Miller E, Becker J, Selnes O, Cohen BA. Normative data for determining significance of test-retest differences on eight common neuropsychological instruments. Clin Neuro-psychol 2004; 18:373-384.
29. Lewis MS, Maruff P, Silbert BS, Evered LA, Scott DA. The sensitivity and specificity of three common statistical rules for the classification of postoperative cognitive dysfunction following coronary artery bypass graft surgery. Acta Anaes-thesiol Scand 2006; 50:50-57.
30. Salthouse TA. Implications of within-person variability in cognitive and neuropsychological functioning for the interpretation of change. Neuropsychology 2007; 21:401-411.
31. Salthouse TA, Tucker-Drob EM. Implications of short-term retest effects for the interpretation of longitudinal change. Neuropsychology 2008; 22:800-811.
32. McArthur J, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, et al. Attenuated CNS infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 2004; 61:1687-1696.
33. Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, et al. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology 2004; 63:2084-2090.
34. Cysique LA, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, et al. Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr 2005; 39:426-429.
35. Heaton RK, Franklin D, Clifford D, Woods S, Rivera Mindt M, Vigil O, et al. HIV-associated neurocognitive impairment remains prevalentinthe era of combination ART: the CHARTER study. In: 16th Conference on Retroviruses and Opportunistic Infections. Montreal, Canada: http://www.retroconference.org/2009/ Abstracts/35664.htm; 2009. p. 154.
36. Brew BJ, Crowe SM, Landay A, Cysique LA, Guillemin G. Neurodegeneration and ageing in the HAART era. J Neuro-immune Pharmacol 2008; 6:6.
37. Sacktor NC, Bacellar H, Hoover DR, Nance-Sproson TE, Selnes OA, Miller EN, et al. Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol 1996; 2:404-410.